Drug firm Strides Pharma Science on Friday reported a consolidated net profit of Rs 141.91 crore for the September quarter.
The company had posted a loss of Rs 8.70 crore for the corresponding period of the previous fiscal, Strides Pharma Science said in a BSE filing.
Consolidated total income stood at Rs 728.08 crore for the quarter under consideration as against Rs 529.46 crore for the same period year ago.
"This quarter's financial results validate our reset strategy, with enhanced focus on growth and margin opportunities from regulated markets," Strides Pharma Science Group CEO and MD Arun Kumar said.
These markets now contribute to over 85 per cent of company's revenues, establishing the strength of its operating model built around diversified markets and carefully selected product portfolio, he added.
Shares of Strides Pharma Science were trading at Rs 366.45 apiece on the BSE, up 6.39 per cent over previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app